Bouret, Josephine

Bouret, Josephine was paid $118K by Medicaid between Nov 2018 and Dec 2021, across 6 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 38% of everything it billed.

33Billing provider infoBOURET, JOSEPHINE
BOSTON, MA 02114

33aNPI1912007022assigned 09/25/2006

33bProvider typeNurse Practitioner

28Total paid$118K

24GClaims2,312

24DCodes billed6

24AFirst – last monthNov 2018 – Dec 2021

Compared with peers

Next to other Nurse Practitioner providers in Massachusetts

Rank by total paid#16 of 172

Median peer was paid$8K

This provider vs. median15×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	44	$2K
2019	352	$13K
2020	800	$39K
2021	1,116	$64K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	38%	1,110	851	$45K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	29%	454	336	$34K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	24%	542	416	$29K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	7.5%	122	107	$9K
99406		<1%	64	51	$646.64
98967		<1%	20	19	$353.77

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.